secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0000310764-24-000062
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q1 sales $5.2B (+9.7%), organic +10.0%; lifts FY organic growth view to 8.5-9.5%, adj. EPS $11.85-$12.05
--------------------------------------------------------------------------------

- Reported EPS $2.05 (+33.1%); adjusted EPS $2.50 (+16.8%).
- MedSurg & Neurotechnology organic sales +11.6%; Orthopaedics & Spine organic +8.0%.
- Reported operating margin 18.5%; adjusted operating margin 21.9% (+80 bps).
- FY 2024 organic net sales growth now expected 8.5% to 9.5% (prior range not disclosed).
- Adjusted EPS guidance raised to $11.85-$12.05; expects negative FX impact of $0.05-$0.10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000062/0000310764-24-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000062/syk-20240430.htm
  HTML page:      https://secwatch.observer/filing/0000310764-24-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer